Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.

Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target

Karakas, Didem, Ozpolat, Bulent · 2020 · Journal of Molecular Medicine

Abstract

Eukaryotic elongation factor-2 kinase (eEF2K), an atypical member of alpha-kinase family, is highly overexpressed in breast, pancreatic, brain, and lung cancers, and associated with poor survival in patients. eEF2K promotes cell proliferation, survival, and aggressive tumor characteristics, leading to tumor growth and progression. While initial studies indicated that eEF2K acts as a negative regulator of protein synthesis by suppressing peptide elongation phase, later studies demonstrated that it has multiple functions and promotes cell cycle, angiogenesis, migration, and invasion as well as induction of epithelial-mesenchymal transition through induction of integrin β1, SRC/FAK, PI3K/AKT, cyclin D1, VEGF, ZEB1, Snail, and MMP-2. Under stress conditions such as hypoxia and metabolic distress, eEF2K is activated by several signaling pathways and slows down protein synthesis and helping cells to save energy and survive. In vivo therapeutic targeting of eEF2K by genetic methods inhibits tumor growth in various tumor models, validating it as a potential molecular target. Recent studies suggest that eEF2K plays a role in tumor microenvironment cells by monocyte chemoattractant protein-1 (MCP-1) and accumulation of tumor-associated macrophages. Due to its clinical significance and the pivotal role in tumorigenesis and progression, eEF2K is considered as an important therapeutic target in solid tumors. However, currently, there is no specific and potent inhibitor for translation into clinical studies. Here, we aim to systematically review current knowledge regarding eEF2K in tumor biology, microenvironment, and development of eEF2K targeted inhibitors and therapeutics.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00109-020-01917-8

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 122 references

Research works printed but not linked: 1

  1. Tavernarakis N (2013) Protein synthesis. In: Vijg J, Campisi J, Lithgow G (eds) The molecular and cellular biology of aging. Gerontological Society of America (GSA) Press, Washington DC

Cited by

See all 55

Metadata

Authors
Karakas, D., & Ozpolat, B.
Affiliations
The University of Texas MD Anderson Cancer Center (US)
Corresponding author
Ozpolat, Bulent
Venue
Journal of Molecular Medicine
Published
2020-05-07
Volume
98
Issue
6
Pages
775-787
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W3023135453
Cited by
54
References
122
Citations by year
2026: 9 · 2025: 16 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 2
FWCI
0.84
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
eEF2K, tumor microenvironment, tumor cell proliferation, epithelial-mesenchymal transition, hypoxia, tumor-associated macrophages, MCP-1, PI3K/Akt signaling, targeted cancer therapy, protein synthesis regulation
MeSH terms
Animals, Autophagy, Disease Susceptibility, Enzyme Activation, Humans, Neoplasms, Protein Conformation, Structure-Activity Relationship, Biomarkers, Tumor, Signal Transduction, Gene Expression, Gene Expression Regulation, Neoplastic, Apoptosis, RNA, Untranslated, Protein Kinase Inhibitors, Elongation Factor 2 Kinase, Molecular Targeted Therapy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. https://app.cochat.ai/papers/10.1007/s00109-020-01917-8
The paper
Karakas, D., & Ozpolat, B. (2020). Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-020-01917-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.